|
|
|
°©»ó¼±ÃÊÀ½ÆÄ¿Í ÁßÀç : QRÄÚµå·Î µ¿¿µ»ó °ÀÇ Á¦°ø
|
|
|
±èÀº°æ
¤Ó
±ÔÀå
|
|
|
|
- Á¦ÈÞ¸ô ÁÖ¹® ½Ã °í°´º¸»ó, ÀϺΠÀ̺¥Æ® Âü¿© ¹× ÁõÁ¤Ç° ÁõÁ¤, ÇÏ·ç/´çÀÏ ¹è¼Û¿¡¼ Á¦¿ÜµÇ¹Ç·Î Âü°í ¹Ù¶ø´Ï´Ù.
-
-
-
ÀÌ Ã¥Àº °©»ó¼±ÃÊÀ½ÆÄ¿¡ °üÇÑ ÃʽÉÀڵ鵵 ½±°Ô Á¢ÇÒ ¼ö ÀÖµµ·Ï »çÁø¿¡ ÀÚ¼¼ÇÑ ¼³¸íÀ» µ¡ºÙÀÌ°í, ÀÏ·¯½ºÆ®·¹À̼ÇÀ» Ãß°¡ÇÏ¿© ÀÌÇØ°¡ ½±µµ·Ï ÇÏ¿´´Ù.
-
-
Chapter 1 °©»ó¼±°áÀý°ú °©»ó¼±¾ÏÀÇ ¿ªÇÐ 3
01. °©»ó¼±°áÀýÀÇ ºóµµ 4
02. °©»ó¼±¾ÏÀÇ ºóµµ¿Í »ç¸Á·ü 4
03. °ËÁøÀ» ÇÏ´Â ÀÌ·ÐÀû ¹è°æ 12
04. °úÀ×Áø·á¿Í °úÀ×Ä¡·á¸¦ ÁÙÀÌ°íÀÚ ÇÏ´Â ³ë·Â 14
Chapter 2 Á¤»ó°æºÎÃÊÀ½ÆÄ 19
01. ÃÊÀ½ÆÄÀåºñ ¹× ±â¹ý 20
1. Àåºñ 20
2. ±â¹ý 21
(A) ÃÊÀ½ÆÄÀÇ ¹üÀ§ 22
(B) ÃÊÀ½ÆÄ¿µ»óÀÇ adjustment¿Í Ç¥Áö 31
(C) ÃÊÀ½ÆÄÀÇ artifacts¿¡ ÀÇÇÑ ¿µ»ó¼Ò°ß 37
02. °æºÎÃÊÀ½ÆÄÀÇ Áß¿äÇÑ ±¸Á¶¹° 40
1. °©»ó¼± 40
(A) ¹ß»ý 40
(B) Á¤»ó°©»ó¼± 42
2. °©»ó¼± ¿Ü °æºÎÀÇ Áß¿äÇÑ ±¸Á¶¹° 60
(A) ¸²ÇÁÀý 60
(B) ºÎ°©»ó¼± 61
(C) Vallecula¿Í pyriform sinus 62
(D) Thyroid cartilage¿Í cricoid cartilage 64
(E) ½Äµµ 68
(F) °æºÎ Àü¸é°ú Ãø¸é ±ÙÀ°, ½Å°æ, ±×¸®°í ôÃß 70
3. CT and MRI ¿µ»ó°úÀÇ ºñ±³ 81
03. °æºÎÃÊÀ½ÆÄ¿¡¼ °©»ó¼±º´º¯À¸·Î ¿ÀÀÎÇÒ ¼ö ÀÖ´Â º´º¯µé 84
1. Mediastinal mass 85
2. Lymph node enlargement 86
3. Parathyroid adenoma/hyperplasia 87
4. Esophageal diverticulum 88
5. Paratracheal air cyst 98
6. Thymus¿Í intrathyroidal thymus 100
7. Schwannoma 101
8. Others 103
04. °©»ó¼±°ú ÁÖº¯ÀÇ developmental and anatomical vari...ations 105
1. Ectopic thyroid tissue 106
2. Thyroid hemiagenesis 109
3. Thyroglossal duct cyst 109
4. Pyramidal lobe 112
5. Zuckerkandl tubercle 113
6. Thyrothymic thyroid rest 114
7. Intrathyroidal fat 115
8. Branchial cleft anomaly 115
9. Lymphangioma 121
10. Dermoid cyst 122
05. °í½ÄÀûÃÊÀ½ÆÄ¿¡ µµ¿òÀ» ÁÖ´Â ±â¹ýµé 124
1. µµÇ÷¯¿µ»ó 124
2. »ïÂ÷¿ø¿µ»ó 126
3. ź¼ºÃÊÀ½ÆÄ 127
(A) ź¼ºÃÊÀ½ÆÄÀÇ ¿ø¸® 127
(B) °©»ó¼±°áÀýÀÇ Áø´Ü¿¡ ÀÖ¾î ź¼ºÃÊÀ½ÆÄ 128
(C) °áÀýÁø´Ü ÀÌ¿ÜÀÇ ÀÓ»óÀû Àû¿ë 131
Chapter 3 ±¹¼Ò°©»ó¼±Áúȯ
01. Thyroid Imaging Reporting and Data System (TIRADS) 139
1. Korean TIRADS (K-TIRADS) 141
(A) Lexicon 142
(B) Categorization 153
(C) FNA indication based on K-TIRADS 158
2. American College of Radiology TIRADS (ACR TIRADS) 160
(A) Lexicon 160
(B) FNA indication based on ACR TIRADS 162
3. Comparison of K-TIRADS with ACR TIRADS 164
(A) Lexicon 164
(B) Size cut-off for FNA 166
4. The risk stratification systems according to a time sequence 166
(A) 2002³â Kim et al¡¯s risk stratification system 166
(B) 2005³â Society of Radiologists in Ultrasound consensus conference statement 167
(C) 2007³â NCCN Clinical Practice Guidelines in Oncology¢â Thyroid Carcinoma V.2.2007 167
(D) 2009³â Horvath et al¡¯s TIRADS 168
(E) 2009³â Park et al¡¯s TIRADS 169
(F) 2011³â Kwak et al¡¯s TIRADS 169
(G) 2014³â British Thyroid Association Guidelines for the Management of Thyroid Cancer 170
(H) 2015³â American Thyroid Association Management Guidelines 171
(I) 2016³â American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines 172
(J) 2016³â Korean TIRADS 172
(K) 2017³â European Thyroid Association Guidelines, EU-TIRADS 173
(L) 2017³â ACR TIRADS 173
(M) 2020³â Chinese TIRADS 174
(N) 2021³â Revised K-TIRADS 174
02. How to select nodules to perform FNA? 175
03. How to learn? 185
04. Clinical application of artificial intelligence 188
1. ¿©·¯ °¡Áö ÄÄÇ»Åͺ¸Á¶Áø´Ü ÇÁ·Î±×·¥ 188
2. ÄÄÇ»Åͺ¸Á¶Áø´Ü ÇÁ·Î±×·¥ÀÇ Áø´Ü¼ºÀû 189
3. ÄÄÇ»Åͺ¸Á¶Áø´Ü ÇÁ·Î±×·¥ °ü·Ã Áõ·Êµé 190
(A) ¾î¶² °ÍÀÌ °áÀýÀΰ¡? 190
(B) °æÇèÀÌ ´Ù¸¥ Àǻ翡 ÀÇÇÑ ½Ç½Ã°£ ÃÊÀ½ÆÄ»çÁø 191
(C) Áߵ°æÇèÀ» °¡Áø ÀÇ»çµéÀÇ ÃÖÁ¾Áø´Ü°ú ÄÄÇ»Åͺ¸Á¶Áø´Ü ÇÁ·Î±×·¥ÀÇ °á°ú 192
4. ÄÄÇ»Åͺ¸Á¶Áø´Ü ÇÁ·Î±×·¥ÀÇ ÇÔÁ¤ 194
Chapter 4 °©»ó¼±°áÀýÁø´Ü ¹× ÃßÀû 201
01. ½Ã¼ú Àü ¹Ýµå½Ã ±â¾ïÇØ¾ß ÇÒ ³»¿ë 202
02. °©»ó¼±°áÀýÁø´ÜÀ» À§ÇÑ ¹æ¹ýµé 203
1. US-guided fine needle aspiration biopsy (US-FNA) 204
(A) Pre-procedural evaluations 204
(B) Procedure 208
(C) Post-procedure compression 213
(D) Complications 214
(E) Bethesda system 217
2. ºÐÀÚÀ¯ÀüÇÐÀû °Ë»ç 226
(A) BRAF mutation 226
(B) Molecular panel 228
(C) ºÐÀÚÀ¯ÀüÇÐÀû °Ë»çÀÇ ÀåÁ¡°ú ¹®Á¦Á¡ 229
3. US-guided core needle biopsy (US-CNB) 229
(A) Pre-procedural evaluations 229
(B) Procedure 230
(C) Post-procedure compression 234
(D) Complications 234
(E) CNB ÀûÀÀÁõ 239
(F) Á¶Á÷°Ë»ç°á°ú º¸°í 241
03. ÃßÀû°Ë»ç 242
1. Thyroid nodules not indicated for FNA 242
2. Thyroid nodules with benign cytology 244
3. Thyroid nodules with two consecutive benign cytology 244
4. Thyroid nodules with nondiagnostic cytology 244
5. Thyroid nodules with AUS/FLUS cytology 245
04. ºñ¼ö¼úÀû Ä¡·á 246
1. Simple aspiration 246
2. Ethanol ablation 248
(A) Cystic and predominantly cystic nodules 249
(B) Recurrent thyroid cancer 252
3. Radiofrequency ablation 254
(A) ¿ø¸® 254
(B) ½Ã¼ú Àü óġ 254
(C) ½Ã¼ú Àåºñ ¹× ¹æ¹ý 255
(D) ½Ã¼ú ¼ºÀû 258
(E) ÇÕº´Áõ 260
Chapter 5 °©»ó¼±¾ÏÀÇ ´Éµ¿°¨½Ã 267
01. ´Éµ¿°¨½ÃÀÇ ±Ù°Å 268
02. ´Éµ¿°¨½ÃÀÇ ´ë»ó°ú °í·ÁÇÒ Á¡ 270
03. ÇØ°áÇØ¾ß ÇÒ °úÁ¦ 274
04. Áõ·Ê 276
Chapter 6 °©»ó¼±¾ÏÀÇ ¼ö¼ú Àü º´±â°áÁ¤ 283
01. °©»ó¼±¾ÏÀÇ º´±â 285
02. °©»ó¼±¾ÏÀÇ Ä¡·á¹æ¹ý 292
03. ¼ö¼ú Àü º´±â°áÁ¤ 294
1. T º´±â°áÁ¤ 294
2. N º´±â°áÁ¤ 303
(A) ¸²ÇÁÀý À§Ä¡ÀÇ Ç¥±â 305
(B) ¸²ÇÁÀýÀüÀ̸¦ ½Ã»çÇÏ´Â ¿µ»ó¼Ò°ß 306
(C) ¸²ÇÁÀý FNA 311
3. M º´±â°áÁ¤ 313
Chapter 7 The 2022 WHO Classification of Thyroid Neoplasms 321
01. A summary of changes in the new WHO classification 322
02. Follicular cell-derived neoplasms 325
1. Benign tumors 325
(A) Thyroid follicular nodular disease 325
(B) Follicular adenoma 326
(C) Follicular adenoma with papillary architecture 326
(D) Oncocytic adenoma of the thyroid 328
2. Low-risk neoplasms 328
(A) Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) 329
(B) Thyroid tumors of uncertain malignant potential 331
(C) Hyalinizing trabecular tumor 332
3. Malignant neoplasms 332
(A) Follicular thyroid carcinoma 332
(B) Invasive encapsulated follicular variant papillary carcinoma 336
(C) Papillary thyroid carcinoma 336
(D) Oncocytic carcinoma of the thyroid 343
(E) Follicular-derived carcinomas, high-grade 344
(F) Anaplastic follicular cell-derived thyroid carcinoma 347
03. Thyroid C-cell-derived carcinoma 349
1. Medullary thyroid carcinoma 349
04. Mixed medullary and follicular cell-derived carcinoma 351
05. Others 352
1. Salivary gland-type carcinomas of the thyroid 352
(A) Mucoepidermoid carcinoma of the thyroid 352
(B) Secretory carcinoma of salivary gland type 353
2. Thyroid tumors of uncertain histogenesis 354
(A) Sclerosing mucoepidermoid carcinoma with eosinophilia (SMECE) 354
(B) Cribriform-morular thyroid carcinoma 354
3. Thymic tumors within the thyroid 356
(A) Thymoma family (intrathyroid thymic tumors) 356
(B) Spindle epithelial tumor with thymus-like elements (SETTLE) 356
(C) Thymic carcinoma family (Intrathyroid thymic carcinoma) 358
4. Embryonal thyroid neoplasms 358
Chapter 8 °©»ó¼±¾Ï ¼ö¼ú ÈÄ ÃßÀû°Ë»ç 363
01. °©»ó¼±¾ÏÀÇ ¸²ÇÁÀýÀüÀÌ ºóµµ ¹× °íÂû 364
02. ÃßÀû°Ë»ç¹æ¹ýµé 366
1. Ç÷û °©»ó¼±±Û·Îºí¸° 366
2. Ç÷û °©»ó¼±±Û·Îºí¸°Ç×ü 367
3. °æºÎÃÊÀ½ÆÄ 368
(A) Àç¹ß¾Ï 369
(B) Àç¹ß·Î ¿ÀÀÎÇÒ ¼ö ÀÖ´Â º´º¯µé 372
03. °©»ó¼±¾Ï ȯÀÚÀÇ Àç¹ß À§Çèµµ ¿¹Ãø 377
Chapter 9 ¹Ì¸¸°©»ó¼±Áúȯ 385
01. Diffuse thyroid disease 388
1. Graves¡¯ disease 388
2. Chronic lymphocytic thyroiditis (Hashimoto¡¯s thyroiditis) 390
3. Painless thyroiditis (subacute lymphocytic thyroiditis) 395
4. Subacute thyroiditis
(subacute granulomatous thyroiditis, De Quervain¡¯s disease) 397
5. Infectious disease of the thyroid gland 398
6. Drug-induced thyroiditis 400
7. Thyroid follicular nodular disease (multinodular goiter) 401
8. Riedel¡¯s thyroiditis 404
9. Subclinical hypothyroidism 405
10. COVID-19 and thyroid disease 405
02. Diagnostic value of ultrasound for diffuse thyroid disease 407
Chapter 10 ºÎ°©»ó¼±°ú ±âŸ °æºÎÃÊÀ½ÆÄ 413
01. ºÎ°©»ó¼±ÃÊÀ½ÆÄ 414
1. ºÎ°©»ó¼±ÀÇ Á¤»óÇغÎÇÐ 415
2. ºÎ°©»ó¼±ÀÇ Á¤»óÃÊÀ½ÆÄ¼Ò°ß ¹× ÃÊÀ½ÆÄ°Ë»çÀÇ ÀûÀÀÁõ 416
3. ºÎ°©»ó¼±¿ì¿¬Á¾ 419
4. ºÎ°©»ó¼±Ç×ÁøÁõ ȯÀÚ¿¡¼ ¼ö¼ú Àü À§Ä¡°áÁ¤ 421
5. ºÎ°©»ó¼±º´º¯ÀÇ FNA¿Í ÁßÀç½Ã¼ú 428
02. ±âŸ °æºÎÃÊÀ½ÆÄ 431
1. ħ»ù 431
2. ¸²ÇÁÀý ¹× ±âŸ 438
Chapter 11 °©»ó¼±°ú ºÎ°©»ó¼±ÀÇ ÇÙÀÇÇÐ ¿µ»ó°Ë»ç 445
01. °©»ó¼±°áÀý 446
1. °©»ó¼±½ºÄµ 446
2. F-18 FDG PET/CT¿¡¼ ¹ß°ßµÈ °©»ó¼±¿ì¿¬Á¾ 449
02. ºÐÈ°©»ó¼±¾Ï 453
1. RAI scan and SPECT/CT 453
(A) ¼ö¼ú ÈÄ pre-ablation ½Ã±âÀÇ diagnostic scan 454
(B) ¹æ»ç¼º¿ä¿Àµå Ä¡·á ÈÄ post-therapy scan 454
(C) Long-term follow-up ½Ã±âÀÇ diagnostic scan 457
2. F-18 FDG PET/CT 457
03. °©»ó¼±¼öÁú¾Ï 460
1. F-18 FDG PET/CT 460
2. F-18 FDOPA PET/CT 461
3. Ga-68 SSA PET/CT 462
04. ºÎ°©»ó¼±Ç×ÁøÁõ 463
1. Tc-99m MIBI scan and SPECT/CT 464
2. C-11 MET PET/CT 466
3. C-11 or F-18 Choline PET/CT 466
»öÀÎ 472
-
-
¼¹® 1
2006³â ¡¸°©»ó¼±ÃÊÀ½ÆÄÇС¹À¸·Î ½ÃÀÛÇÑ Ã¥ÀÌ ¹ú½á 5ÆÇÀÌ ³ª¿Â °ÍÀ» º¸¸é »ì¾ÆÀִ åÀº ¸¸µé°í ½Í´Ù´Â ÀÇÁö°¡ ¾î´ÀÁ¤µµ ¹Ý¿µµÈ °Í °°¾Æ »ÑµíÇÏ´Ù.
À̹ø °³Á¤ÆÇ¿¡´Â °æºÏ´ë ±èÇýÁ¤±³¼ö°¡ ÀúÀÚ·Î Âü¿©ÇÏ¿© ±×°£ ºÎÁ·Çß´ø ¼¶¼¼ÇÔÀ» µå·¯³½ °ÍÀÌ ¸Å¿ì ÈíÁ·ÇÏ´Ù. º´¸®, ÇÙÀÇÇкоßÀÇ Àü¹®°¡¸¦ ¸ð¼Å¼ chapter¸¦ ´õ º¸°ÇÑ °Íµµ ¸Å¿ì °¨»çÇÑ ÀÏÀÌ´Ù. ¿©·¯ »ç¶÷ÀÇ µµ¿òÀ¸·Î ¿©±â±îÁö ¿Â °Í¿¡ °¨»çÇÑ´Ù.
À̹ø Ã¥¿¡¼´Â ÃʽÉÀڵ鵵 ½±°Ô Á¢ÇÒ ¼ö ÀÖµµ·Ï »çÁø¿¡ ÀÚ¼¼ÇÑ ¼³¸íÀ» µ¡ºÙÀÌ°í, ÀÏ·¯½ºÆ®·¹À̼ÇÀ» Ãß°¡ÇÏ¿© ÀÌÇØ°¡ ½±µµ·Ï ÇÏ¿´´Ù.
¿µ»óÀÇÇÐÀü¹®ÀÇ°¡ µÇ°í ½Ã°£ÀÌ Áö³¯¼ö·Ï, ã¾Æ¿À´Â ȯÀڵ鿡 ´ëÇØ °¨»çÇϸç, °Ë»ç ÇϳªÇϳª¸¦ ¼º½É²¯ ÇÏ°í, Æǵ¶ÇϳªÇϳª¸¦ ÃÖ¼±À» ´ÙÇØ ÇؾßÇÑ´Ù´Â ¸¶À½ÀÌ ´õ Àý½ÇÇÏ´Ù. ³ªÇÑÅ× °Ë»ç¸¦ ¹ÞÀ¸·¯ ¿À´Â °ÍÀº ´ç¿¬ÇÔÀÌ ¾Æ´Ï¶ó °í¸¶¿òÀÌ´Ù.
Áö±ÝÀÇ ³»°¡ Àֱ⠱îÁö ¸¹Àº µµ¿òÀ» ÁֽŠ±³¼ö´Ô, µ¿·áµé, ÈĹèµé¿¡°Ô °¨»çÇÏ¸ç ¾ðÁ¦³ª ÈûÀÌ µÇ´Â °¡Á·µé, ¸ÃÀº ºÐ¾ß¿¡ ÃÖ¼±À» ´ÙÇ϶ó°í °Ý·ÁÇØÁֽôø ºÎ¸ð´Ô²² ¿µ±¤À» µ¹¸°´Ù.
2023. 04
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿µ»óÀÇÇаú ±³¼ö
±èÀº°æ
¼¹® 2
2001³â Æç·Î¿ì¸¦ ÇÏ°í ÀÌ ºÐ¾ß¸¦ ¾÷À¸·Î 23³â°¸¦ ¸Â°íÀÖ´Ù. ÀÌ ±â°£ µ¿¾È ¾ð·ÐÀÇ °úÀ×Áø·á³í¶õµµ ÀÖ¾ú°í ÃÊÀ½ÆÄ ±Þ¿©È¶ó´Â Å« º¯Èµµ ÀÖ¾ú´Ù. ÃÊÀ½ÆÄ´Â °Ë»çÀÇ Æ¯¼º»ó Áø·áÀ̱⵵ Çϱ⿡ 20³â ³Ñ´Â ȯÀÚ Áø·á¿¡¼ Áö±ÝÀÌ °©»ó¼± Ȥ¿¡ ´ëÇÑ È¯ÀÚÀÇ ±Ù½ÉÀÌ ÃÖ°íÁ¶¿¡ À̸£Áö ¾Ê¾Ò³ª ÇÏ´Â »ý°¢ÀÌ µç´Ù.
Á¡Á¡ ´õ ¸¹Àº Àǻ簡 ÀÌ ºÐ¾ß¿¡ ÁøÀÔÇÏ°í ÀÖ°í ´õ ¸¹Àº »ç¶÷µéÀÌ °©»ó¼± ȤÀ» °¡Áø ȯÀÚ°¡ µÇ°í ÀÖ´Ù. ¶ÇÇÑ ´õ ¸¹Àº °Ë»ç¿Í ½Ã¼úµéÀÌ ÁøÇàµÇ°í ÀÖ´Ù. ÀÌ·± Çö½Ç ¼Ó¿¡¼ 3¸íÀÇ ±³¼öµéÀÌ ¸Ó¸®¸¦ ¸Â´ë°í Çö½ÃÁ¡¿¡¼ °¡Àå ÇÊ¿äÇÑ Áöħ¼¸¦ ¸¶·ÃÇÏ°íÀÚ ³ë·ÂÇÏ¿´´Ù. ÀÌ Ã¥¿¡´Â ÀúÀÚÀÇ ¸àÅäÀ̽Š±èÀº°æ ¿øÀå´ÔÀÇ Ã¶ÇÐÀÌ, ÀúÀÚÀÇ ½ÇÁ¦ÀûÀÎ °æÇèÀÌ, ±èÇýÁ¤ ±³¼öÀÇ ³ë·ÂÀÌ °í½º¶õÈ÷ ´ã°ÜÀÖ´Ù. Ã¥ÀÇ ¿Ï¼ºµµ·Î ÃÊÁ¶ÇÒ ¶§ ¾ðÁ¦³ª Áß½ÉÀ» Àâ¾ÆÁֽŠ¿øÀå´Ô°ú ¹ã³·À» °¡¸®Áö ¾Ê°í ±ÄÀºÀÏÀ» ¸¶´ÙÇÏÁö ¾ÊÀº ±èÇýÁ¤ ±³¼ö¿¡°Ô ±íÀº °¨»ç¸¦ µå¸°´Ù.
¾î´À»õ 5ÆÇÀ» ¸ÂÀÌÇÑ ÀÌ Ã¥Àº ÀÌÀüº¸´Ù ´õ ¸¹Àº »ç¶÷µéÀÇ µµ¿òÀ¸·Î ¿Ï¼ºµÇ¾ú´Ù. Ç×»ó Àü¹®¼º¿¡ ºÎÁ·ÇÔÀÌ ÀÖ´ø ºÎºÐÀ» ÇÙÀÇÇаú ÀÌ»ó¿ì ±³¼ö´Ô°ú º´¸®°ú ½ÅÀº¾Æ ±³¼ö´ÔÀÇ µµ¿òÀ¸·Î ¿Ï¼ºµµ¸¦ ³ôÀÏ ¼ö ÀÖ¾ú±â¿¡ µÎ ºÐ²² °¨»ç¸¦ µå¸°´Ù. »ó´çÇÑ ¾çÀÇ °ËÅ並 ÈçÄèÈ÷ ÁøÇàÇØ Á̴ּø °¨¼öÀڵ鿡°Ôµµ ±íÀº °¨»ç¸¦ µå¸®¸ç ÀÌ ºÐµé·Î ÀÎÇØ µ¶ÀÚÀÇ °üÁ¡±îÁö °í·ÁÇÑ ÆíÁýÀ» ÁøÇàÇÒ ¼ö ÀÖ¾ú´Ù. ÀÌ ÀÛ¾÷ÀÌ °¡´ÉÇÒ ¼ö ÀÖ¾ú´ø °ÍÀº ÀηÂÀÌ ºÎÁ·ÇÑ ¾ÇÁ¶°Ç ¼Ó¿¡¼ ¼·Î ÀÇÁöÇÏ°í ¹è·ÁÇÏ¸é¼ ÆÄÆ®¸¦ ¹¬¹¬È÷ ÁöÄÑÁÖ°í ÀÖ´Â ±è¹ÎÁ¤, À±Á¤Çö, ¹Ú¿µÁø, ³ë¹Ì¸®ºñ, À±Áö¿µ ±³¼öÀÇ ´öºÐÀÌ°í ÀÌ Ã¥À» ºô¾î °¨»ç¸¦ ÀüÇÑ´Ù.
±×¸®¿î ºÎ¸ð´Ôµé, ¾ðÁ¦³ª ÀÚ½ÄÀ» À§ÇØ ±âµµÇϽô ¾î¸Ó´Ï, ³Ê¹« »ç¶ûÇÏ´Â ¿µÀºÀÌ, ¿µ°üÀÌ, ±×¸®°í ÀÌ »ç¶÷¾øÀÌ »ç´Â °ÍÀ» »ó»óÇÒ ¼ö ¾ø´Â ³²Æí ±èÈ£Áß ¿øÀå´Ô²² Æò¼Ò ÀüÇÏÁö ¸øÇÑ °¨»ç¿Í »ç¶ûÀ» ÀüÇÑ´Ù. ¸¶Áö¸·À¸·Î ºÎÁ·ÇÑ ³» ¾È¿¡ ½Ã°£À» ÅëÇØ ¿ª»çÇϽô ÁÖ´Ô²² °¨»çµå¸®°í ³» ÀÇÁö°¡ ¾Æ´Ñ ±× ºÐÀÇ ¶æÀ¸·Î ³ªÀÇ ³ª¸ÓÁö ÀλýÀÌ Ã¤¿öÁö±æ ¹Ù·¡º»´Ù.
2023. 04
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿µ»óÀÇÇаú ±³¼ö
°ûÁø¿µ
¼¹® 3
¹ã 10½Ã ±×¸®°í »õº® 1½Ã...
º´¿ø ¿¬±¸½Ç¿¡¼ ¡¸°©»ó¼±ÃÊÀ½ÆÄ¿Í ÁßÀ硹 °³Á¤ 5ÆÇÀ» À§ÇØ ³í¹®°ú Ã¥À» º¸¸ç ¿öµåÀÛ¾÷À» ÇÏ´Ù ½Ã°è¸¦ º¸´Ï ¹ã 10½Ã¿´´Ù. ÀÌÁ¦ Á¶±Ý¸¸ ´õÇÏ°í Áý¿¡ °¡¾ßÁö ÇÑ ÈÄ ´Ù½Ã ½Ã°è¸¦ ºÃÀ» ¶§´Â »õº® 1½Ã. ¹«Ã´ °¨°Ý½º·¯¿î ¼ø°£À̾ú´Ù. ½Ã°£°¡´Â ÁÙ ¸ð¸£°í ÀÌ·¸°Ô ÁýÁßÇÑ ÀûÀÌ ¾ó¸¶ ¸¸À̾ú´ø°¡! ÀÌ ÀÛ¾÷ÀÌ ¹«Ã´ Èûµé°í °íµÈ ½Ã°£À̱ä ÇßÁö¸¸ ¿ÀÈ÷·Á ¿©·¯°¡Áö ...Èûµç »óȲÀÌ »ý±æ ¶§¸¶´Ù ³ª¸¦ ¹öƼ°Ô ÇÏ´Â ÈûÀ̱⵵ Çß´Ù. ´©±º°¡¿¡°Ô µµ¿òÀÌ µÉ ¼ö ÀÖ´Â ÀÏÀ» ÇÏ´Â °ÍÀº Âü °¡½¿ ¹÷Âù ÀÏÀÌ´Ù. ÀÌ Ã¥ÀÌ °©»ó¼±ÃÊÀ½Æĸ¦ ÇÏ´Â ºÐµé²² ¿ä±äÇÑ °¡À̵尡 µÇ±â¸¦ °£ÀýÈ÷ ¹Ù¶õ´Ù.
»ç½Ç ³ª´Â ÀÌ Ã¥ÀÇ °³Á¤ÀÛ¾÷¿¡ Âü¿©Çϱ⿡´Â µÎ ºÐÀÇ ÈǸ¢ÇϽŠÀúÀںе鿡 ºñÇØ ÅξøÀÌ ºÎÁ·ÇÑ »ç¶÷ÀÌ´Ù. °ç¿¡¼ Ã¥À» ÃâÆÇÇÏ°í Áö¼ÓÀûÀ¸·Î °³Á¤ÇϽô °É º¸¸ç À̺еéÀÌ ´ë´ÜÇØ º¸¿´°í ºÎ·¯¿ü´Ù. µü Çѹø, ³ªµµ ÇÒ ¼ö ÀÖÀ¸¸é ÁÁ°Ú´Ù°í ¾î·ÅDzÀÌ »ý°¢ÇÑ ÀûÀÌ ÀÖ¾úÁö¸¸ ÁÖÁ¦³ÑÀº »ý°¢À̶ó¸ç ¹Ù·Î Á¢¾ú¾ú´Âµ¥ ÀÌ·¸°Ô ÀúÀÚ·Î Âü¿©ÇÏ°Ô µÇ´Ù´Ï Á¤¸» ²Þ¸¸ °°´Ù. ³ª¸¦ À¯¹æ°ú °©»ó¼± ¿µ»óÀÇ ±æ·Î µé¾î¼µµ·Ï ±×¸®°í ÀÌ ÀÛ¾÷À» ¹«»çÈ÷ ¿Ï¼ºÇÒ ¼ö ÀÖ°Ô À̲ø¾îÁֽŠ³ªÀÇ ¸àÅä °ûÁø¿µ ±³¼ö´Ô, ³Ê¹«³ª ÈǸ¢Çϼż Èä³» ³»±âÁ¶Â÷ ¾î·Á¿î ·Ñ ¸ðµ¨À̽Š±èÀº°æ ±³¼ö´Ô²² ÁøÇÑ °¨»çÀÇ ¸»¾¸À» µå¸°´Ù. Ã¥ ¼¹®¸¶´Ù ¿Ö ´Ùµé ´ÙÀ½°ú °°ÀÌ ¾²½Ç±î Çߴµ¥ ¸·»ó Çغ¸´Ï ¾Ë°Ú´Ù. Ã¥À» ¾´´Ù¸ç ¿©·¯ °¡Áö¿¡ ¼ÒȦÇß´ø ¾Æ³»¸¦ ¹¬¹¬È÷ Áö¿øÇØ ÁØ ³²Æí ÀÌ½Â¿ì °úÀå´Ô°ú ½º½º·Î ¾Ë¾Æ¼ Àß ÀÚ¶ó ÁØ µÎ µþ ¼ö°æ, ¼ö¿¬¿¡°Ô °¨»çÀÇ ¸»À» ÀüÇÑ´Ù. ¹Ù»Û µþ°ú ¸ç´À¸®¸¦ ÀÌÇØÇÏ°í ÁöÄѺÁ ÁֽŠµÎ ºÎ¸ð´Ôµé²²µµ °¨»çµå¸°´Ù. ³ª¸¦ ¿©±â±îÁö ÀÖ°Ô ÇØ ÁֽŠÁÖº¯ÀÇ ¸ðµç ºÐµé²²µµ °¨»çµå¸®¸ç, ¹«¾ùº¸´Ù ºÎÁ·ÇÑ ³ª¸¦ À̲ø¾î ÀÌ ÀÏÀ» ¿ÏÁÖÇÏ°Ô ÇÏ½Ã°í ±×ÀÇ ¶æ´ë·Î ÀÌ·ç½Ç ÀºÇý¿Í ´É·ÂÀÇ Çϳª´Ô²² ±íÀº °¨»ç¸¦ µå¸°´Ù.
2023. 04
°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¿µ»óÀÇÇаú ±³¼ö
±èÇýÁ¤
-
-
|
±èÀº°æ [Àú]
|
|
-
¿µ»óÀÇÇаú Àü¹®ÀÇ, ÀÇÇйڻç´Ù. ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ Á¹¾÷, ¿¬¼¼´ëÇб³ ´ëÇпø ÀÇÇйڻçÀÌ¸ç ¿¬¼¼ÀÇ´ë ½ÅÃ̼¼ºê¶õ½ºº´¿ø Àü°øÀÇ ¼ö·áÇß´Ù. University of North Carolina ºÎ¼Óº´¿ø ¹æ»ç¼±°ú ¿¬¼öÇßÀ¸¸ç ÇöÀç ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿µ»óÀÇÇб³½Ç ±³¼ö, ´ëÇÑÀ¯¹æ¿µ»óÀÇÇÐȸ ÇмúÀÌ»ç, ´ëÇÑ°©»ó¼±¿µ»óÀÇÇÐȸ ¿¬±¸ÀÌ»ç, ´ëÇÑÃÊÀ½ÆÄÀÇÇÐȸ °£ÇàÀÌ»ç, KJR, ´ëÇÑ¿µ»óÀÇÇÐȸÁö ½É»çÀ§¿øÀÌ´Ù.
-
-
Àüü 0°³ÀÇ ±¸¸ÅÈıⰡ ÀÖ½À´Ï´Ù.
|
ÀÎÅÍÆÄÅ©µµ¼´Â °í°´´ÔÀÇ ´Ü¼ø º¯½É¿¡ ÀÇÇÑ ±³È¯°ú ¹ÝÇ°¿¡ µå´Â ºñ¿ëÀº °í°´´ÔÀÌ ÁöºÒÄÉ µË´Ï´Ù.
´Ü, »óÇ°À̳ª ¼ºñ½º ÀÚüÀÇ ÇÏÀÚ·Î ÀÎÇÑ ±³È¯ ¹× ¹ÝÇ°Àº ¹«·á·Î ¹ÝÇ° µË´Ï´Ù. |
|
±³È¯ ¹× ¹ÝÇ°ÀÌ °¡´ÉÇÑ °æ¿ì |
»óÇ°À» °ø±Þ ¹ÞÀº ³¯·ÎºÎÅÍ 7ÀÏÀ̳» °¡´É
°ø±Þ¹ÞÀ¸½Å »óÇ°ÀÇ ³»¿ëÀÌ Ç¥½Ã, ±¤°í ³»¿ë°ú ´Ù¸£°Å³ª ´Ù¸£°Ô ÀÌÇàµÈ °æ¿ì¿¡´Â °ø±Þ¹ÞÀº ³¯·ÎºÎÅÍ 3°³¿ù À̳», ȤÀº ±×»ç½ÇÀ» ¾Ë°Ô µÈ ³¯ ¶Ç´Â ¾Ë ¼ö ÀÖ¾ú´ø ³¯·ÎºÎÅÍ 30ÀÏ À̳»
»óÇ°¿¡ ¾Æ¹«·± ÇÏÀÚ°¡ ¾ø´Â °æ¿ì ¼ÒºñÀÚÀÇ °í°´º¯½É¿¡ ÀÇÇÑ ±³È¯Àº »óÇ°ÀÇ Æ÷Àå»óÅ µîÀÌ ÀüÇô ¼Õ»óµÇÁö ¾ÊÀº °æ¿ì¿¡ ÇÑÇÏ¿© °¡´É |
|
±³È¯ ¹× ¹ÝÇ°ÀÌ ºÒ°¡´ÉÇÑ °æ¿ì |
±¸¸ÅÈ®Á¤ ÀÌÈÄ(¿ÀǸ¶ÄÏ»óÇ°¿¡ ÇÑÇÔ)
°í°´´ÔÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¸ê½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì
(´Ü, »óÇ°ÀÇ ³»¿ëÀ» È®ÀÎÇϱâ À§ÇÏ¿© Æ÷Àå µîÀ» ÈѼÕÇÑ °æ¿ì´Â Á¦¿Ü)
½Ã°£ÀÌ Áö³²¿¡ µû¶ó ÀçÆǸŰ¡ °ï¶õÇÒ Á¤µµ·Î ¹°Ç°ÀÇ °¡Ä¡°¡ ¶³¾îÁø °æ¿ì
Æ÷Àå °³ºÀµÇ¾î »óÇ° °¡Ä¡°¡ ÈÑ¼ÕµÈ °æ¿ì |
|
´Ù¹è¼ÛÁöÀÇ °æ¿ì ¹ÝÇ° ȯºÒ |
´Ù¹è¼ÛÁöÀÇ °æ¿ì ´Ù¸¥ Áö¿ªÀÇ ¹ÝÇ°À» µ¿½Ã¿¡ ÁøÇàÇÒ ¼ö ¾ø½À´Ï´Ù.
1°³ Áö¿ªÀÇ ¹ÝÇ°ÀÌ ¿Ï·áµÈ ÈÄ ´Ù¸¥ Áö¿ª ¹ÝÇ°À» ÁøÇàÇÒ ¼ö ÀÖÀ¸¹Ç·Î, ÀÌÁ¡ ¾çÇØÇØ Áֽñ⠹ٶø´Ï´Ù. |
|
Áß°í»óÇ°ÀÇ ±³È¯ |
Áß°í»óÇ°Àº Á¦ÇÑµÈ Àç°í ³»¿¡¼ ÆǸŰ¡ ÀÌ·ç¾îÁö¹Ç·Î, ±³È¯Àº ºÒ°¡´ÉÇÕ´Ï´Ù. |
|
¿ÀǸ¶ÄÏ »óÇ°ÀÇ È¯ºÒ |
¿ÀǸ¶ÄÏ»óÇ°¿¡ ´ëÇÑ Ã¥ÀÓÀº ¿øÄ¢ÀûÀ¸·Î ¾÷ü¿¡°Ô ÀÖÀ¸¹Ç·Î, ±³È¯/¹ÝÇ° Á¢¼ö½Ã ¹Ýµå½Ã ÆǸÅÀÚ¿Í ÇùÀÇ ÈÄ ¹ÝÇ° Á¢¼ö¸¦ ÇϼžßÇϸç, ¹ÝÇ°Á¢¼ö ¾øÀÌ ¹Ý¼ÛÇϰųª, ¿ìÆíÀ¸·Î º¸³¾ °æ¿ì »óÇ° È®ÀÎÀÌ ¾î·Á¿ö ȯºÒÀÌ ºÒ°¡´ÉÇÒ ¼ö ÀÖÀ¸´Ï À¯ÀÇÇϽñ⠹ٶø´Ï´Ù. |
|
|
|
¹è¼Û¿¹Á¤ÀÏ ¾È³» |
ÀÎÅÍÆÄÅ© µµ¼´Â ¸ðµç »óÇ°¿¡ ´ëÇØ ¹è¼Û¿Ï·á¿¹Á¤ÀÏÀ» À¥»çÀÌÆ®¿¡ Ç¥½ÃÇÏ°í ÀÖ½À´Ï´Ù.
|
<ÀÎÅÍÆÄÅ© Á÷¹è¼Û »óÇ°> |
»óÇ°Àº ¿ù~Åä¿äÀÏ ¿ÀÀü 10½Ã ÀÌÀü ÁÖ¹®ºÐ¿¡ ´ëÇÏ¿© ´çÀÏ Ãâ°í/´çÀÏ ¹è¼Û¿Ï·á¸¦ º¸ÀåÇÏ´Â »óÇ°ÀÔ´Ï´Ù. |
»óÇ°Àº ¼¿ïÁö¿ª/ÆòÀÏ ÁÖ¹®ºÐÀº ´çÀÏ Ãâ°í/ÀÍÀÏ ¹è¼Û¿Ï·á¸¦ º¸ÀåÇϸç,
¼¿ï¿ÜÁö¿ª/ÆòÀÏ ÁÖ¹®ºÐÀÇ °æ¿ì´Â ¿ÀÈÄ 6½Ã±îÁö ÁÖ¹®ºÐ¿¡ ´ëÇÏ¿© ÀÍÀÏ ¹è¼Û¿Ï·á¸¦ º¸ÀåÇÏ´Â »óÇ°ÀÔ´Ï´Ù.
(´Ü, ¿ù¿äÀÏÀº 12½Ã±îÁö ÁÖ¹®¿¡ ÇÑÇÔ)
|
»óÇ°Àº, ÀÔ°í¿¹Á¤ÀÏ(Á¦Ç°Ãâ½ÃÀÏ)+Åùè»ç¹è¼ÛÀÏ(1ÀÏ)¿¡ ¹è¼Û¿Ï·á¸¦ º¸ÀåÇÕ´Ï´Ù. |
~
»óÇ°Àº À¯ÅëƯ¼º»ó ÀÎÅÍÆÄÅ©¿¡¼ Àç°í¸¦ º¸À¯ÇÏÁö ¾ÊÀº »óÇ°À¸·Î ÁÖ¹®ÀÏ+±âÁØÃâ°íÀÏ+Åùè»ç¹è¼ÛÀÏ(1ÀÏ)¿¡ ¹è¼Û¿Ï·á¸¦ º¸ÀåÇÕ´Ï´Ù.(Åä/°øÈÞÀÏÀº ¹è¼Û±â°£¿¡ Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù.)
¡Ø±âÁØÃâ°íÀÏ:ÀÎÅÍÆÄÅ©°¡ »óÇ°À» ¼ö±ÞÇÏ¿© ¹°·ùâ°í¿¡¼ Æ÷Àå/Ãâ°íÇϱâ±îÁö ¼Ò¿äµÇ´Â ½Ã°£
|
|
<¾÷ü Á÷Á¢¹è¼Û/¿ÀǸ¶ÄÏ »óÇ°> |
~
»óÇ°Àº ¾÷ü°¡ ÁÖ¹®À» È®ÀÎÇÏ°í, Ãâ°íÇϱâ±îÁö °É¸®´Â ½Ã°£ÀÔ´Ï´Ù. ÁÖ¹®ÀÏ+±âÁØÃâ°íÀÏ+Åùè»ç¹è¼ÛÀÏ(2ÀÏ)¿¡ ¹è¼Û¿Ï·á¸¦ º¸ÀåÇÕ´Ï´Ù.(Åä/°øÈÞÀÏÀº ¹è¼Û±â°£¿¡ Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù.)
¡Ø5ÀÏÀ̳» Ãâ°í°¡ ½ÃÀÛµÇÁö ¾ÊÀ»½Ã, ¿ÀǸ¶ÄÏ »óÇ°Àº ÀÚµ¿À¸·Î ÁÖ¹®ÀÌ Ãë¼ÒµÇ¸ç, °í°´´Ô²² Ç°Àýº¸»ó±ÝÀ» Áö±ÞÇØ µå¸³´Ï´Ù.
|
|
|
¹è¼Ûºñ ¾È³» |
µµ¼(Áß°íµµ¼ Æ÷ÇÔ)¸¸ ±¸¸ÅÇϽøé : ¹è¼Ûºñ 2,000¿ø (1¸¸¿øÀÌ»ó ±¸¸Å ½Ã ¹«·á¹è¼Û) À½¹Ý/DVD¸¸ ±¸¸ÅÇϽøé : ¹è¼Ûºñ 1,500¿ø (2¸¸¿øÀÌ»ó ±¸¸Å ½Ã ¹«·á¹è¼Û)
ÀâÁö/¸¸È/±âÇÁÆ®¸¸ ±¸¸ÅÇϽøé : ¹è¼Ûºñ 2,000¿ø (2¸¸¿øÀÌ»ó ±¸¸Å ½Ã ¹«·á¹è¼Û)
µµ¼¿Í À½¹Ý/DVD¸¦ ÇÔ²² ±¸¸ÅÇϽøé : ¹è¼Ûºñ 1,500¿ø 1¸¸¿øÀÌ»ó ±¸¸Å ½Ã ¹«·á¹è¼Û)
µµ¼¿Í ÀâÁö/¸¸È/±âÇÁÆ®/Áß°íÁ÷¹è¼Û»óÇ°À» ÇÔ²² ±¸¸ÅÇϽøé : 2,000¿ø (1¸¸¿øÀÌ»ó ±¸¸Å ½Ã ¹«·á¹è¼Û)
¾÷üÁ÷Á¢¹è¼Û»óÇ°À» ±¸¸Å½Ã : ¾÷üº°·Î »óÀÌÇÑ ¹è¼Ûºñ Àû¿ë
* ¼¼Æ®»óÇ°ÀÇ °æ¿ì ºÎºÐÃë¼Ò ½Ã Ãß°¡ ¹è¼Ûºñ°¡ ºÎ°úµÉ ¼ö ÀÖ½À´Ï´Ù.
* ºÏÄ«Æ®¿¡¼ ¹è¼Ûºñ¾ø¾Ö±â ¹öÆ°À» Ŭ¸¯Çϼż, µ¿ÀϾ÷ü»óÇ°À» Á¶±Ý ´õ ±¸¸ÅÇϽøé, ¹è¼Ûºñ¸¦ Àý¾àÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
|
|
Çؿܹè¼Û ¾È³» |
ÀÎÅÍÆÄÅ©µµ¼¿¡¼´Â ±¹³»¿¡¼ ÁÖ¹®ÇϽðųª ÇØ¿Ü¿¡¼ ÁÖ¹®ÇÏ¿© ÇØ¿Ü·Î ¹è¼ÛÀ» ¿øÇÏ½Ç °æ¿ì DHL°ú Ư¾àÀ¸·Î Ã¥Á¤µÈ ¿ä±ÝÇ¥¿¡
ÀÇÇØ °³ÀÎÀÌ ÀÌ¿ëÇÏ´Â °æ¿ìº¸´Ù ¹è¼Û¿ä±ÝÀ» Å©°Ô ³·Ã߸ç DHL(www.dhl.co.kr)·Î Çؿܹè¼Û ¼ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù.
Çؿܹè¼ÛÀº µµ¼/CD/DVD »óÇ°¿¡ ÇÑÇØ ¼ºñ½ºÇÏ°í ÀÖÀ¸¸ç, ´Ù¸¥ »óÇ°À» ºÏÄ«Æ®¿¡ ÇÔ²² ´ãÀ¸½Ç °æ¿ì Çؿܹè¼ÛÀÌ ºÒ°¡ÇÕ´Ï´Ù.
ÇØ¿ÜÁÖ¹®¹è¼Û ¼ºñ½º´Â ÀÎÅÍÆÄÅ© µµ¼ ȸ¿ø °¡ÀÔÀ» Çϼž߸¸ ½Åû °¡´ÉÇÕ´Ï´Ù. |
|
¾Ë¾ÆµÎ¼¼¿ä!!! |
µµ¸Å»ó ¹× Á¦ÀÛ»ç »çÁ¤¿¡ µû¶ó Ç°Àý/ÀýÆÇ µîÀÇ »çÀ¯·Î Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.
¿ÀǸ¶ÄϾ÷üÀÇ ¹è¼ÛÁö¿¬½Ã ÁÖ¹®ÀÌ ÀÚµ¿À¸·Î Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.
Ãâ°í°¡´É ½Ã°£ÀÌ ¼·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.
À¯ÅëÀÇ Æ¯¼º»ó Ãâ°í±â°£Àº ¿¹Á¤º¸´Ù ¾Õ´ç°ÜÁö°Å³ª ´ÊÃçÁú ¼ö ÀÖ½À´Ï´Ù.
Åùè»ç ¹è¼ÛÀÏÀÎ ¼¿ï ¹× ¼öµµ±ÇÀº 1~2ÀÏ, Áö¹æÀº 2~3ÀÏ, µµ¼, »ê°£, ±ººÎ´ë´Â 3ÀÏ ÀÌ»óÀÇ ½Ã°£ÀÌ ¼Ò¿äµË´Ï´Ù. |
|
|
|
|